The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Update with TapImmune, Inc. - Discusses Target Indications, Clinical Development, Milestones and Goals for 2016

SNNLive caught up with Glynn Wilson, Ph.D., Chairman & CEO of TapImmune, Inc. (OTCQB: TPIV) at the Source Capital 2016 Disruptive Growth & Healthcare Conference in New York City, NY.

Share With

Thursday, March 17, 2016

   

© 2017 Stock News Now